Inmune Bio (INMB) Free Cash Flow (2018 - 2025)
Historic Free Cash Flow for Inmune Bio (INMB) over the last 8 years, with Q3 2025 value amounting to -$5.6 million.
- Inmune Bio's Free Cash Flow rose 1939.59% to -$5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.9 million, marking a year-over-year decrease of 1984.56%. This contributed to the annual value of -$33.4 million for FY2024, which is 17833.33% down from last year.
- Inmune Bio's Free Cash Flow amounted to -$5.6 million in Q3 2025, which was up 1939.59% from -$7.4 million recorded in Q2 2025.
- Over the past 5 years, Inmune Bio's Free Cash Flow peaked at -$1.1 million during Q1 2023, and registered a low of -$11.1 million during Q4 2024.
- Moreover, its 5-year median value for Free Cash Flow was -$5.7 million (2021), whereas its average is -$6.1 million.
- Per our database at Business Quant, Inmune Bio's Free Cash Flow surged by 8712.92% in 2023 and then tumbled by 55521.47% in 2024.
- Over the past 5 years, Inmune Bio's Free Cash Flow (Quarter) stood at -$9.8 million in 2021, then soared by 41.77% to -$5.7 million in 2022, then soared by 39.93% to -$3.4 million in 2023, then tumbled by 223.06% to -$11.1 million in 2024, then surged by 49.05% to -$5.6 million in 2025.
- Its Free Cash Flow was -$5.6 million in Q3 2025, compared to -$7.4 million in Q2 2025 and -$6.8 million in Q1 2025.